Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Journal of Experimental Hematology
>
2013
>
21
>
6
Volume:
21
Issue:
6
1. Role of CD47 in hematologic malignancies.
Page:1631—1634
2. Clinical progress of paroxysmal nocturnal hemoglobinuria.
Page:1627—1630
3. Research progress on B lymphocyte-induced maturation protein 1 and its relationship with the development of lymphoma.
Page:1623—1626
4. Present status of individualized therapy in childhood acute lymphoblastic leukemia.
Page:1617—1622
5. Effect of glutathione on blood coagulation function.
Page:1612—1616
6. Optimization of conditions for human erythropoiesis in human-mouse xenotransplant model.
Page:1606—1611
7. Identification and analysis of the rare HLA-A/B/DRB1 allele genes of 10165 bone marrow registry donors in Shaanxi region.
Page:1602—1605
8. Ex vivo inducing cultured Epstein-Barr virus specific cytotoxic T lymphocytes and evaluation of their killing effect.
Page:1597—1601
9. Activation of NOD2 signalling pathway stimulates the function of human dendritic cells loaded with leukemia cell lysates.
Page:1591—1596
10. Immunophenotypic characteristics of peripheral blood cells in normal elderly men.
Page:1585—1590
11. Effects of HOXB4-transfecting directly and HOXB4-transfected HUCMSC on in vitro expansion of human umbilical cord blood CD34+ cells.
Page:1578—1584
12. Effect of salidroside on apoptosis of bone marrow mesenchymal stem cells induced by ara-C.
Page:1572—1577
13. TNF-α stimulates bone marrow mesenchymal stem cell VCAM-1 production by ERK signaling pathway.
Page:1568—1571
14. A new method for isolating and culturing mouse bone marrow mesenchymal stem cells.
Page:1563—1567
15. Effect of 15-deoxy-Δ(12), 14-prostaglandin J2 on the cytokines in the culture supernatant of bone marrow mesenchymal stem cells.
Page:1557—1562
16. Long term in-vitro expansion reduces immune modulation function of placental chorionic villi mesenchymal stem cells.
Page:1552—1556
17. Effect of interfering the β-catenin by lentiviral vector-mediated RNAi on the biological behavior of mouse bone marrow mesenchymal stem cells.
Page:1546—1551
18. Effect of PTD-mFoxp3 fusion protein on graft-versus-host disease after allogeneic bone marrow transplantation.
Page:1541—1545
19. Clinical study on recombinant humanized anti-CD25 monoclonal antibody used for treating steroid-resistant acute graft versus host disease following allo-hematopoietic stem cell transplantation.
Page:1535—1540
20. Relation of reinfused hematopoietic stem cell volume and recipient's leukocyte count at reinfusion with prognosis of disease in allo-hematopoietic stem cell transplantation.
Page:1530—1534
21. Source and effect of IL-22 in graft versus host disease mouse after allo-genetic bone marrow transplantation.
Page:1526—1529
22. Transplantation of haploidentical-hematopoietic stem cells combined with two kind of third part cells for chronic aplastic anemia: one case report.
Page:1522—1525
23. Correlation of Breg with CD4(+)T cells of peripheral blood in patients with CITP and its clinical significance.
Page:1517—1521
24. Distribution and activation of dendritic cells in immune thrombocytopenia patients.
Page:1513—1516
25. Study of single nucleotide polymorphism of SOCS gene in typical myeloproliferative neoplasms.
Page:1507—1512
26. Comprehensive analysis of genomic detection for a patient with myelodysplastic syndrome.
Page:1501—1506
27. Effect of flumatinib mesylate on C-MYC, HIF-1α and VEGF in U226 line.
Page:1496—1500
28. Prognostic value of serum IL-6 in patients with multiple myeloma.
Page:1492—1495
29. Macrocalin A induces apoptosis of multiple myeloma U266 cells through inhibiting the proteasome.
Page:1486—1491
30. Effect of bortezomib combined with bisphosphonates on bone metabolism index in multiple myeloma.
Page:1482—1485
31. Curative efficacy for nasal type extranodal NK/T-cell lymphoma by autologous peripheral blood stem cell transplantation after sequencing chemotherapy and radiotherapy.
Page:1477—1481
32. Clinical observation and long-time follow-up of patients with malignant lymphoma treated with autologous peripheral blood hematopoietic stem cell transplantation.
Page:1471—1476
33. Analysis for clinicopathological features, therapy and prognosis of 30 elderly patients with non-Hodgkin's lymphoma.
Page:1464—1470
34. Effect of midazolam on mantle cell lymphoma JeKo-1 cell line and its relevant mechanisms.
Page:1460—1463
35. Blocking effect of arsenic trioxide on the proliferation and cell cycle of human Burkitt lymphoma cells and its related mechanism.
Page:1454—1459
36. Analysis of clinical features and prognostic factors in 59 cases of follicular lymphoma.
Page:1448—1453
37. Mechanism of inhibiting the cell growth in diffuse large B-cell lymphoma by valproic acid combined with temsirolimus.
Page:1441—1447
38. Prognostic significance of detecting MLL-AF9 fusion gene expression in patients with acute myeloid leukemia by real-time fluorescence quantitative PCR.
Page:1435—1440
39. Effects of matrine on the expression of NKG2D ligands in leukemia cells.
Page:1429—1434
40. Molecular mechanism of SHI-1 cell apoptosis induced by puerariae radix flavones in vitro.
Page:1423—1428
41. Reversing effects of emodin on multidrug resistance in resistant HL-60/ADR cells.
Page:1413—1422
42. Clinical and pathological analysis of 41 cases of acute leukemia combined with intracranial hemorrhage.
Page:1409—1412
43. Characteristics of NOTCH1 mutation in adult T-cell acute lymphoblastic leukemia.
Page:1403—1408
44. Inhibitory effect of PD98059 on MAPK signaling pathway in acute lymphocytic leukemia cells.
Page:1399—1402
45. Effect of AML1-ETO fusion protein on the expression of BCL-2.
Page:1394—1398
46. Construction of hybridoma cells with IL1RAP as a new marker for leukemia stem cells and detection of its monoclonal antibody.
Page:1390—1393
47. Immunophenotypic and clinical characteristic analysis of NPM1 mutated acute myeloid leukemia with a normal karyotype.
Page:1385—1389
48. Roles of NKG2D in cytokine-induced killer (CIK) against hematological malignant cells lines.
Page:1380—1384
49. Establishment of hematological malignancy model in ex vivo cell culture.
Page:1373—1379
50. Unraveling the chromosome higher-order structures in the transcriptional regulation of hematopoiesis by chromosome conformation capture.
Page:1369—1372